Anti-IAPP Monoclonal Antibody Improves Clinical Symptoms in a Mouse Model of Type 2 Diabetes

Type 2 Diabetes Mellitus (T2DM) is a chronic progressive disease, defined by insulin resistance and insufficient insulin secretion to maintain normoglycemia. Amyloidogenic aggregates are a hallmark of T2DM patients; they are cytotoxic for the insulin producing β-cells, and cause inflammasome-depende...

Descripción completa

Detalles Bibliográficos
Autores principales: Vogt, Anne-Cathrine S., Roesti, Elisa S., Mohsen, Mona O., Leonchiks, Ainars, Vogel, Monique, Bachmann, Martin F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8622146/
https://www.ncbi.nlm.nih.gov/pubmed/34835247
http://dx.doi.org/10.3390/vaccines9111316

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8622146/
https://www.ncbi.nlm.nih.gov/pubmed/34835247
http://dx.doi.org/10.3390/vaccines9111316

Ejemplares similares